{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T18:07:11Z","timestamp":1790532431818,"version":"4.1.0"},"reference-count":182,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T00:00:00Z","timestamp":1724025600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T00:00:00Z","timestamp":1724025600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s10787-024-01556-2","type":"journal-article","created":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T15:02:02Z","timestamp":1724079722000},"page":"2753-2779","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Review on the role of nucleotide-binding oligomerization domain-like receptor protein 3 (NLRP3) inflammasome pathway in diabetes: mechanistic insights and therapeutic implications"],"prefix":"10.1007","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-7325-0745","authenticated-orcid":false,"given":"Abhishek","family":"Satheesan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1355-5833","authenticated-orcid":false,"given":"Janardanan","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kakithakara Vajravelu","family":"Leela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ria","family":"Murugesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkata","family":"Chaithanya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matcha","family":"Angelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,19]]},"reference":[{"key":"1556_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.121390","volume":"316","author":"AA Alzokaky","year":"2023","unstructured":"Alzokaky AA et al (2023) Metformin ameliorates doxorubicin-induced cardiotoxicity targeting HMGB1\/TLR4\/NLRP3 signaling pathway in mice. Life Sci 316:121390","journal-title":"Life Sci"},{"issue":"5","key":"1556_CR2","first-page":"895","volume":"72","author":"NB Amaral","year":"2023","unstructured":"Amaral NB et al (2023) Colchicine reduces the activation of NLRP3 inflammasome in COVID-19 patients. Inflamm Res off J Eur Histamine Res Soc 72(5):895\u2013899","journal-title":"Inflamm Res off J Eur Histamine Res Soc"},{"key":"1556_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2022.121275","volume":"314","author":"FM Amin","year":"2023","unstructured":"Amin FM, Shehatou GSG, Nader MA, Abdelaziz RR (2023) Piperine mitigates aortic vasculopathy in streptozotocin-diabetic rats via targeting TXNIP-NLRP3 signaling. Life Sci 314:121275","journal-title":"Life Sci"},{"key":"1556_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.119743","volume":"280","author":"HH Arab","year":"2021","unstructured":"Arab HH, Ashour AM, Gad AM, Mahmoud AM, Kabel AM (2021) Activation of AMPK\/mTOR-driven autophagy and inhibition of NLRP3 inflammasome by saxagliptin ameliorate ethanol-induced gastric mucosal damage. Life Sci 280:119743","journal-title":"Life Sci"},{"issue":"1","key":"1556_CR5","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s10787-023-01301-1","volume":"32","author":"AM Awad","year":"2024","unstructured":"Awad AM, Elshaer SL, Gangaraju R, Abdelaziz RR, Nader MA (2024) Ameliorative effect of montelukast against STZ induced diabetic nephropathy: targeting HMGB1, TLR4, NF-\u03baB, NLRP3 inflammasome, and autophagy pathways. Inflammopharmacology 32(1):495\u2013508","journal-title":"Inflammopharmacology"},{"issue":"1","key":"1556_CR6","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2016-000227","volume":"4","author":"Y Birnbaum","year":"2016","unstructured":"Birnbaum Y, Bajaj M, Qian J, Ye Y (2016) Dipeptidyl peptidase-4 inhibition by Saxagliptin prevents inflammation and renal injury by targeting the Nlrp3\/ASC inflammasome. BMJ Open Diabetes Res & Care 4(1):e000227","journal-title":"BMJ Open Diabetes Res & Care"},{"issue":"5","key":"1556_CR7","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s00395-019-0743-0","volume":"114","author":"Y Birnbaum","year":"2019","unstructured":"Birnbaum Y, Tran D, Bajaj M, Ye Y (2019) DPP-4 inhibition by linagliptin prevents cardiac dysfunction and inflammation by targeting the Nlrp3\/ASC inflammasome. Basic Res Cardiol 114(5):35","journal-title":"Basic Res Cardiol"},{"key":"1556_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2021.152720","volume":"453","author":"J Cai","year":"2021","unstructured":"Cai J et al (2021) NLRP3 inflammasome mediated pyroptosis is involved in cadmium exposure-induced neuroinflammation through the IL-1\u03b2\/IkB-\u03b1-NF-\u03baB-NLRP3 feedback loop in swine. Toxicology 453:152720","journal-title":"Toxicology"},{"issue":"13","key":"1556_CR9","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1167\/iovs.61.13.12","volume":"61","author":"H Chen","year":"2020","unstructured":"Chen H et al (2020) Identification of NLRP3 inflammation-related gene promoter hypomethylation in diabetic retinopathy. Invest Ophthalmol vis Sci 61(13):12","journal-title":"Invest Ophthalmol vis Sci"},{"issue":"4","key":"1556_CR10","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s10557-020-06978-y","volume":"34","author":"H Chen","year":"2020","unstructured":"Chen H, Tran D, Yang H-C, Nylander S, Birnbaum Y, Ye Y (2020a) Dapagliflozin and ticagrelor have additive effects on the attenuation of the activation of the NLRP3 inflammasome and the progression of diabetic cardiomyopathy: an AMPK\u2013mTOR interplay. Cardiovasc Drugs Ther 34(4):443\u2013461","journal-title":"Cardiovasc Drugs Ther"},{"issue":"7","key":"1556_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2020.127021","volume":"30","author":"Y Chen","year":"2020","unstructured":"Chen Y et al (2020b) Discovery and optimization of 4-oxo-2-thioxo-thiazolidinones as NOD-like receptor (NLR) family, pyrin domain-containing protein 3 (NLRP3) inhibitors. Bioorg Med Chem Lett 30(7):127021","journal-title":"Bioorg Med Chem Lett"},{"issue":"1","key":"1556_CR12","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1186\/s12974-022-02669-7","volume":"19","author":"W Chen","year":"2022","unstructured":"Chen W et al (2022) The upregulation of NLRP3 inflammasome in dorsal root ganglion by ten-eleven translocation methylcytosine dioxygenase 2 (TET2) contributed to diabetic neuropathic pain in mice. J Neuroinflammation 19(1):302","journal-title":"J Neuroinflammation"},{"issue":"3","key":"1556_CR13","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/imm.13628","volume":"169","author":"L-C Chen","year":"2023","unstructured":"Chen L-C et al (2023) Inactivation of mitochondrial pyruvate carrier promotes NLRP3 inflammasome activation and gout development via metabolic reprogramming. Immunology 169(3):271\u2013291","journal-title":"Immunology"},{"issue":"1","key":"1556_CR14","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1093\/stmcls\/sxad078","volume":"42","author":"Y Chen","year":"2024","unstructured":"Chen Y et al (2024) MSC-derived small extracellular vesicles alleviate diabetic retinopathy by delivering miR-22-3p to inhibit NLRP3 inflammasome activation. Stem Cells 42(1):64\u201375","journal-title":"Stem Cells"},{"issue":"1","key":"1556_CR15","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.2119\/molmed.2015.00104","volume":"21","author":"F Chiazza","year":"2015","unstructured":"Chiazza F et al (2015) Targeting the NLRP3 inflammasome to Reduce Diet-induced Metabolic Abnormalities in Mice. Mol Med 21(1):1025\u20131037","journal-title":"Mol Med"},{"issue":"3","key":"1556_CR16","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1139\/cjpp-2021-0116","volume":"100","author":"PK Chinta","year":"2022","unstructured":"Chinta PK, Tambe S, Umrani D, Pal AK, Nandave M (2022) Effect of parthenolide, an NLRP3 inflammasome inhibitor, on insulin resistance in high-fat diet-obese mice. Can J Physiol Pharmacol 100(3):272\u2013281","journal-title":"Can J Physiol Pharmacol"},{"key":"1556_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/nu11030516","author":"I-C Chung","year":"2019","unstructured":"Chung I-C et al (2019) Pretreatment with a heat-killed probiotic modulates the NLRP3 inflammasome and attenuates colitis-associated colorectal cancer in mice. Nutrients. https:\/\/doi.org\/10.3390\/nu11030516","journal-title":"Nutrients"},{"issue":"5","key":"1556_CR18","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s10557-014-6539-4","volume":"28","author":"Y Dai","year":"2014","unstructured":"Dai Y, Dai D, Wang X, Ding Z, Mehta JL (2014) DPP-4 inhibitors repress NLRP3 Inflammasome and Interleukin-1beta via GLP-1 receptor in macrophages through protein Kinase C pathway. Cardiovasc Drugs Ther 28(5):425\u2013432","journal-title":"Cardiovasc Drugs Ther"},{"key":"1556_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.102033","volume":"45","author":"X Dai","year":"2021","unstructured":"Dai X et al (2021) Epigenetic regulation of TXNIP-mediated oxidative stress and NLRP3 inflammasome activation contributes to SAHH inhibition-aggravated diabetic nephropathy. Redox Biol 45:102033","journal-title":"Redox Biol"},{"key":"1556_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2020.101833","volume":"39","author":"R Dapueto","year":"2021","unstructured":"Dapueto R et al (2021) A novel nitroalkene vitamin E analogue inhibits the NLRP3 inflammasome and protects against inflammation and glucose intolerance triggered by obesity. Redox Biol 39:101833","journal-title":"Redox Biol"},{"issue":"2","key":"1556_CR21","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.3892\/etm.2020.8864","volume":"20","author":"B Deng","year":"2020","unstructured":"Deng B, Hu Y, Sheng X, Zeng H, Huo Y (2020) miR-223-3p reduces high glucose and high fat-induced endothelial cell injury in diabetic mice by regulating NLRP3 expression. Exp Ther Med 20(2):1514\u20131520","journal-title":"Exp Ther Med"},{"issue":"5","key":"1556_CR22","doi-asserted-by":"publisher","first-page":"899","DOI":"10.5114\/aoms.2012.31621","volume":"8","author":"G Derosa","year":"2012","unstructured":"Derosa G, Maffioli P (2012) \u03b1-Glucosidase inhibitors and their use in clinical practice. Arch Med Sci 8(5):899\u2013906","journal-title":"Arch Med Sci"},{"issue":"7","key":"1556_CR23","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1016\/j.ymthe.2021.03.012","volume":"29","author":"H Ding","year":"2021","unstructured":"Ding H et al (2021) MicroRNA-10 negatively regulates inflammation in diabetic kidney via targeting activation of the NLRP3 inflammasome. Mol Ther 29(7):2308\u20132320","journal-title":"Mol Ther"},{"issue":"1","key":"1556_CR24","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s13019-024-02692-0","volume":"19","author":"T Dong","year":"2024","unstructured":"Dong T, Huang D, Jin Z (2024) Mechanism of sodium butyrate, a metabolite of gut microbiota, regulating cardiac fibroblast transdifferentiation via the NLRP3\/Caspase-1 pyroptosis pathway. J Cardiothorac Surg 19(1):208","journal-title":"J Cardiothorac Surg"},{"issue":"4","key":"1556_CR25","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.cmet.2018.03.001","volume":"27","author":"DJ Drucker","year":"2018","unstructured":"Drucker DJ (2018) Mechanisms of action and therapeutic application of glucagon-like peptide-1. Cell Metab 27(4):740\u2013756","journal-title":"Cell Metab"},{"issue":"7","key":"1556_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.23357","volume":"37","author":"DK Dwivedi","year":"2023","unstructured":"Dwivedi DK, Jena GB (2023) Dimethyl fumarate-mediated Nrf2\/ARE pathway activation and glibenclamide-mediated NLRP3 inflammasome cascade inhibition alleviate type II diabetes-associated fatty liver in rats by mitigating oxidative stress and inflammation. J Biochem Mol Toxicol 37(7):e23357","journal-title":"J Biochem Mol Toxicol"},{"issue":"4","key":"1556_CR27","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1007\/s10787-021-00818-7","volume":"29","author":"MA El-Rous","year":"2021","unstructured":"El-Rous MA, Saber S, Raafat EM, Ahmed AAE (2021) Dapagliflozin, an SGLT2 inhibitor, ameliorates acetic acid-induced colitis in rats by targeting NF\u03baB\/AMPK\/NLRP3 axis. Inflammopharmacology 29(4):1169\u20131185","journal-title":"Inflammopharmacology"},{"key":"1556_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114772","volume":"163","author":"MH ElSayed","year":"2023","unstructured":"ElSayed MH et al (2023) Memantine mitigates ROS\/TXNIP\/NLRP3 signaling and protects against mouse diabetic retinopathy: histopathologic, ultrastructural and bioinformatic studies. Biomed Pharmacother 163:114772","journal-title":"Biomed Pharmacother"},{"issue":"14","key":"1556_CR29","doi-asserted-by":"publisher","first-page":"42390","DOI":"10.1007\/s11356-023-25254-8","volume":"30","author":"NO El-Shaer","year":"2023","unstructured":"El-Shaer NO, Hegazy AM, Muhammad MH (2023) Protective effect of quercetin on pulmonary dysfunction in streptozotocin-induced diabetic rats via inhibition of NLRP3 signaling pathway. Environ Sci Pollut Res 30(14):42390\u201342398","journal-title":"Environ Sci Pollut Res"},{"key":"1556_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24087272","author":"JR Escart\u00edn-Guti\u00e9rrez","year":"2023","unstructured":"Escart\u00edn-Guti\u00e9rrez JR, Ponce-Figueroa M, Torres-Vega M\u00c1, Aguilar-Faisal L, Figueroa-Arredondo P (2023) Transcriptional activation of a pro-inflammatory response (NF-\u03baB, AP-1, IL-1\u03b2) by the Vibrio cholerae cytotoxin (VCC) MONOMER THROUGH the MAPK signaling pathway in the thp-1 human macrophage cell line. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24087272","journal-title":"Int J Mol Sci"},{"key":"1556_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.108825","volume":"109","author":"AH Faghfouri","year":"2022","unstructured":"Faghfouri AH et al (2022) Regulation of NLRP3 inflammasome by zinc supplementation in Beh\u00e7et\u2019s disease patients: a double-blind, randomized placebo-controlled clinical trial. Int Immunopharmacol 109:108825","journal-title":"Int Immunopharmacol"},{"issue":"5","key":"1556_CR32","first-page":"1534","volume":"45","author":"Z Fan","year":"2020","unstructured":"Fan Z, Yang J, Yang C, Zhang J, Cai W, Huang C (2020) MicroRNA-24 attenuates diabetic vascular remodeling by suppressing the NLRP3\/caspase-1\/IL-1\u03b2 signaling pathway Corrigendum in \/10.3892\/ijmm.2022.5079. Int J Mol Med 45(5):1534\u20131542","journal-title":"Int J Mol Med"},{"issue":"10","key":"1556_CR33","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1016\/j.jid.2022.03.025","volume":"142","author":"J Fang","year":"2022","unstructured":"Fang J et al (2022) Advanced glycation end products promote melanogenesis by activating NLRP3 inflammasome in human dermal fibroblasts. J Invest Dermatol 142(10):2591-2602.e8","journal-title":"J Invest Dermatol"},{"issue":"6","key":"1556_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0218384","volume":"14","author":"Y Feng","year":"2019","unstructured":"Feng Y, Huang Y, Wang Y, Wang P, Song H, Wang F (2019) Antibiotics induced intestinal tight junction barrier dysfunction is associated with microbiota dysbiosis, activated NLRP3 inflammasome and autophagy. PLoS ONE 14(6):e0218384","journal-title":"PLoS ONE"},{"issue":"8","key":"1556_CR35","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/s41574-023-00833-4","volume":"19","author":"M Foretz","year":"2023","unstructured":"Foretz M, Guigas B, Viollet B (2023) Metformin: update on mechanisms of action and repurposing potential. Nat Rev Endocrinol 19(8):460\u2013476","journal-title":"Nat Rev Endocrinol"},{"key":"1556_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21176275","author":"U Galicia-Garcia","year":"2020","unstructured":"Galicia-Garcia U et al (2020) pathophysiology of type 2 diabetes mellitus. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21176275","journal-title":"Int J Mol Sci"},{"key":"1556_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2019.172801","volume":"866","author":"Y Gao","year":"2020","unstructured":"Gao Y et al (2020) Ginsenoside Rg1 protects mice against streptozotocin-induced type 1 diabetic by modulating the NLRP3 and Keap1\/Nrf2\/HO-1 pathways. Eur J Pharmacol 866:172801","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"1556_CR38","doi-asserted-by":"publisher","DOI":"10.1111\/cts.13789","volume":"17","author":"E Gatlik","year":"2024","unstructured":"Gatlik E et al (2024) First-in-human safety, tolerability, and pharmacokinetic results of DFV890, an oral low-molecular-weight NLRP3 inhibitor. Clin Transl Sci 17(5):e13789","journal-title":"Clin Transl Sci"},{"key":"1556_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.176241","volume":"963","author":"V Gayatri","year":"2024","unstructured":"Gayatri V, Krishna Prasad M, Mohandas S, Nagarajan S, Kumaran K, Ramkumar KM (2024) Crosstalk between inflammasomes, inflammation, and Nrf 2: implications for gestational diabetes mellitus pathogenesis and therapeutics. Eur J Pharmacol 963:176241","journal-title":"Eur J Pharmacol"},{"key":"1556_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/cells10020314","author":"IM Gora","year":"2021","unstructured":"Gora IM, Ciechanowska A, Ladyzynski P (2021) NLRP3 inflammasome at the interface of inflammation, endothelial dysfunction, and type 2 diabetes. Cells. https:\/\/doi.org\/10.3390\/cells10020314","journal-title":"Cells"},{"issue":"2","key":"1556_CR41","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1139\/cjpp-2021-0399","volume":"100","author":"E Gronda","year":"2022","unstructured":"Gronda E et al (2022) Mechanisms of action of SGLT2 inhibitors and their beneficial effects on the cardiorenal axis. Can J Physiol Pharmacol 100(2):93\u2013106","journal-title":"Can J Physiol Pharmacol"},{"issue":"1","key":"1556_CR42","first-page":"2337363","volume":"2022","author":"A Habas","year":"2022","unstructured":"Habas A et al (2022) NPT1220-312, a TLR2\/TLR9 small molecule antagonist, inhibits pro-inflammatory signaling, cytokine release, and NLRP3 inflammasome activation. Int J Inflam 2022(1):2337363","journal-title":"Int J Inflam"},{"issue":"1","key":"1556_CR43","first-page":"9696303","volume":"2022","author":"L Han","year":"2022","unstructured":"Han L, Xi G, Guo N, Guo J, Rong Q (2022) Expression and mechanism of TXNIP\/NLRP3 inflammasome in sciatic nerve of type 2 diabetic rats. Dis Markers 2022(1):9696303","journal-title":"Dis Markers"},{"key":"1556_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.619103","author":"W Hao","year":"2021","unstructured":"Hao W et al (2021) Xiaoyaosan improves antibiotic-induced depressive-like and anxiety-like behavior in mice through modulating the gut microbiota and regulating the NLRP3 inflammasome in the colon. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2021.619103","journal-title":"Front Pharmacol"},{"issue":"S2","key":"1556_CR45","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1002\/dmrr.249","volume":"18","author":"H Hauner","year":"2002","unstructured":"Hauner H (2002) The mode of action of thiazolidinediones. Diabetes Metab Res Rev 18(S2):S10\u2013S15","journal-title":"Diabetes Metab Res Rev"},{"issue":"3","key":"1556_CR46","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.cmet.2020.01.009","volume":"31","author":"M He","year":"2020","unstructured":"He M et al (2020) An acetylation switch of the NLRP3 inflammasome regulates aging-associated chronic inflammation and insulin resistance. Cell Metab 31(3):580-591.e5","journal-title":"Cell Metab"},{"issue":"10","key":"1556_CR47","doi-asserted-by":"publisher","first-page":"6590","DOI":"10.1007\/s12035-022-02998-x","volume":"59","author":"Y He","year":"2022","unstructured":"He Y et al (2022) Glibenclamide directly prevents neuroinflammation by targeting SUR1-TRPM4-Mediated NLRP3 inflammasome activation in microglia. Mol Neurobiol 59(10):6590\u20136607","journal-title":"Mol Neurobiol"},{"issue":"1","key":"1556_CR48","first-page":"7423661","volume":"2023","author":"J He","year":"2023","unstructured":"He J et al (2023) Astragaloside IV attenuates high-glucose-induced impairment in diabetic nephropathy by increasing klotho expression via the NF-\u03baB\/NLRP3 Axis. J Diabetes Res 2023(1):7423661","journal-title":"J Diabetes Res"},{"issue":"1","key":"1556_CR49","doi-asserted-by":"publisher","first-page":"11824","DOI":"10.1038\/s41598-024-62465-6","volume":"14","author":"W He","year":"2024","unstructured":"He W, Wei J, Liu X, Zhang Z, Huang R, Jiang Z (2024) Semaglutide ameliorates pressure overload-induced cardiac hypertrophy by improving cardiac mitophagy to suppress the activation of NLRP3 inflammasome. Sci Rep 14(1):11824","journal-title":"Sci Rep"},{"issue":"17","key":"1556_CR50","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1002\/cmdc.201700270","volume":"12","author":"JR Hill","year":"2017","unstructured":"Hill JR et al (2017) Sulfonylureas as concomitant insulin secretagogues and NLRP3 inflammasome inhibitors. ChemMedChem 12(17):1449\u20131457","journal-title":"ChemMedChem"},{"issue":"6","key":"1556_CR51","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1189\/jlb.3A0114-005RR","volume":"96","author":"H Honda","year":"2014","unstructured":"Honda H et al (2014) Isoliquiritigenin is a potent inhibitor of NLRP3 inflammasome activation and diet-induced adipose tissue inflammation. J Leukoc Biol 96(6):1087\u20131100","journal-title":"J Leukoc Biol"},{"issue":"1","key":"1556_CR52","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12974-019-1498-0","volume":"16","author":"P Hong","year":"2019","unstructured":"Hong P et al (2019) NLRP3 inflammasome as a potential treatment in ischemic stroke concomitant with diabetes. J Neuroinflammation 16(1):121","journal-title":"J Neuroinflammation"},{"key":"1556_CR53","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.toxlet.2020.06.002","volume":"331","author":"L Hou","year":"2020","unstructured":"Hou L et al (2020) Glibenclamide attenuates 2,5-hexanedione-induced neurotoxicity in the spinal cord of rats through mitigation of NLRP3 inflammasome activation, neuroinflammation and oxidative stress. Toxicol Lett 331:152\u2013158","journal-title":"Toxicol Lett"},{"issue":"6","key":"1556_CR54","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/s41419-021-03813-6","volume":"12","author":"Y Hou","year":"2021","unstructured":"Hou Y, Wang Q, Han B, Chen Y, Qiao X, Wang L (2021) CD36 promotes NLRP3 inflammasome activation via the mtROS pathway in renal tubular epithelial cells of diabetic kidneys. Cell Death Dis 12(6):523","journal-title":"Cell Death Dis"},{"key":"1556_CR55","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.938391","author":"Q Hou","year":"2022","unstructured":"Hou Q et al (2022) Inhibition of HDAC6 With CAY10603 ameliorates diabetic kidney disease by suppressing NLRP3 inflammasome. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2022.938391","journal-title":"Front Pharmacol"},{"issue":"7","key":"1556_CR56","first-page":"1461","volume":"396","author":"J Hu","year":"2023","unstructured":"Hu J et al (2023) Dapagliflozin protects against dilated cardiomyopathy progression by targeting NLRP3 inflammasome activation. Naunyn Schmiedebergs Arch Pharmacol 396(7):1461\u20131470","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"18","key":"1556_CR57","doi-asserted-by":"publisher","first-page":"18181","DOI":"10.18632\/aging.103666","volume":"12","author":"D Huang","year":"2020","unstructured":"Huang D, Gao W, Zhong X, Ge J (2020) NLRP3 activation in endothelia promotes development of diabetes-associated atherosclerosis. Aging 12(18):18181\u201318191","journal-title":"Aging"},{"issue":"1","key":"1556_CR58","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s13098-023-01070-5","volume":"15","author":"L Huang","year":"2023","unstructured":"Huang L, Xiong S, Liu H, Zhang R, Wu Y, Hu X (2023) Silencing LncRNA SNHG16 suppresses the diabetic inflammatory response by targeting the miR-212-3p\/NF-\u03baB signaling pathway. Diabetol Metab Syndr 15(1):119","journal-title":"Diabetol Metab Syndr"},{"key":"1556_CR59","unstructured":"Huang G, Zhang Y, Zhang Y, Zhou X, Xu Y, Wei H, Chen X, Ma Y Oridonin attenuates diabetes\u2011induced renal fibrosis via the inhibition of TXNIP\/NLRP3 and NF\u2011\u03baB pathways by activating PPAR\u03b3 in rats, Exp Clin Endocrinol Diabetes, vol. 0, no. AAM."},{"key":"1556_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.pupt.2021.102003","volume":"67","author":"J Hur","year":"2021","unstructured":"Hur J, Kang JY, Kim YK, Lee SY, Lee HY (2021) Glucagon-like peptide 1 receptor (GLP-1R) agonist relieved asthmatic airway inflammation via suppression of NLRP3 inflammasome activation in obese asthma mice model. Pulm Pharmacol Ther 67:102003","journal-title":"Pulm Pharmacol Ther"},{"issue":"12","key":"1556_CR61","doi-asserted-by":"publisher","first-page":"2738","DOI":"10.3390\/nu15122738","volume":"15","author":"M Iwasa","year":"2023","unstructured":"Iwasa M et al (2023) Taxifolin suppresses inflammatory responses of high-glucose-stimulated mouse microglia by attenuating the TXNIP\u2013NLRP3 axis. Nutrients 15(12):2738","journal-title":"Nutrients"},{"key":"1556_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2024.148509","volume":"919","author":"R Jia","year":"2024","unstructured":"Jia R, Ma H, Hao H, Wang F, Yang H (2024) Metformin inhibits activation of NLRP3 inflammasome and inflammatory response in preeclamptic rats. Gene 919:148509","journal-title":"Gene"},{"key":"1556_CR63","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.molimm.2019.01.006","volume":"107","author":"T Jiang","year":"2019","unstructured":"Jiang T, Jiang D, Zhang L, Ding M, Zhou H (2019) Anagliptin ameliorates high glucose- induced endothelial dysfunction via suppression of NLRP3 inflammasome activation mediated by SIRT1. Mol Immunol 107:54\u201360","journal-title":"Mol Immunol"},{"issue":"1","key":"1556_CR64","doi-asserted-by":"publisher","first-page":"13880","DOI":"10.1038\/s41598-023-41136-y","volume":"13","author":"Z Karami","year":"2023","unstructured":"Karami Z, Mehrzad J, Akrami M, Hosseinkhani S (2023) Anti-inflammation-based treatment of atherosclerosis using Gliclazide-loaded biomimetic nanoghosts. Sci Rep 13(1):13880","journal-title":"Sci Rep"},{"issue":"2","key":"1556_CR65","first-page":"146","volume":"79","author":"B Karim","year":"2024","unstructured":"Karim B et al (2024) Role of colchicine to reduce NLRP3 marker in STEMI patients undergo primary PCI: a randomised controlled clinical trial. Med J Malaysia 79(2):146\u2013150","journal-title":"Med J Malaysia"},{"issue":"11","key":"1556_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2020.165903","volume":"1866","author":"K Karnam","year":"2020","unstructured":"Karnam K et al (2020) HDAC6 inhibitor accelerates wound healing by inhibiting tubulin mediated IL-1\u03b2 secretion in diabetic mice. Biochim Biophys Acta - Mol Basis Dis 1866(11):165903","journal-title":"Biochim Biophys Acta - Mol Basis Dis"},{"issue":"1","key":"1556_CR67","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202100909RR","volume":"36","author":"Q Ke","year":"2022","unstructured":"Ke Q et al (2022) SGLT2 inhibitor counteracts NLRP3 inflammasome via tubular metabolite itaconate in fibrosis kidney. FASEB J 36(1):e22078","journal-title":"FASEB J"},{"issue":"1","key":"1556_CR68","doi-asserted-by":"publisher","first-page":"140","DOI":"10.4103\/ijpvm.IJPVM_229_19","volume":"11","author":"N Khalili","year":"2020","unstructured":"Khalili N, Safavipour A (2020) Evaluation of the effects of acarbose on weight and metabolic, inflammatory, and cardiovascular markers in patients with obesity and overweight. Int J Prev Med 11(1):140","journal-title":"Int J Prev Med"},{"issue":"1","key":"1556_CR69","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1038\/s41467-020-15983-6","volume":"11","author":"SR Kim","year":"2020","unstructured":"Kim SR et al (2020) SGLT2 inhibition modulates NLRP3 inflammasome activity via ketones and insulin in diabetes with cardiovascular disease. Nat Commun 11(1):2127","journal-title":"Nat Commun"},{"key":"1556_CR70","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24129968","author":"D Kim","year":"2023","unstructured":"Kim D, Ban K-Y, Lee G-H, Jun H-S (2023) Lysophosphatidic acid induces podocyte pyroptosis in diabetic nephropathy by an Increase of Egr1 expression via downregulation of EzH2. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24129968","journal-title":"Int J Mol Sci"},{"issue":"11","key":"1556_CR71","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1471","volume":"13","author":"B Klughammer","year":"2023","unstructured":"Klughammer B et al (2023) A randomized, double-blind phase 1b study evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of the NLRP3 inhibitor selnoflast in patients with moderate to severe active ulcerative colitis. Clin Transl Med 13(11):e1471","journal-title":"Clin Transl Med"},{"issue":"4","key":"1556_CR72","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/s41419-022-04786-w","volume":"13","author":"H Kong","year":"2022","unstructured":"Kong H, Zhao H, Chen T, Song Y, Cui Y (2022) Targeted P2X7\/NLRP3 signaling pathway against inflammation, apoptosis, and pyroptosis of retinal endothelial cells in diabetic retinopathy. Cell Death Dis 13(4):336","journal-title":"Cell Death Dis"},{"key":"1556_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2023.110640","volume":"382","author":"X Kong","year":"2023","unstructured":"Kong X et al (2023) Loganin reduces diabetic kidney injury by inhibiting the activation of NLRP3 inflammasome-mediated pyroptosis. Chem Biol Interact 382:110640","journal-title":"Chem Biol Interact"},{"issue":"1","key":"1556_CR74","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s11658-022-00350-8","volume":"27","author":"J Lan","year":"2022","unstructured":"Lan J, Xu B, Shi X, Pan Q, Tao Q (2022) WTAP-mediated N6-methyladenosine modification of NLRP3 mRNA in kidney injury of diabetic nephropathy. Cell Mol Biol Lett 27(1):51","journal-title":"Cell Mol Biol Lett"},{"key":"1556_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.medmic.2024.100106","volume":"20","author":"RH Lathakumari","year":"2024","unstructured":"Lathakumari RH, Vajravelu LK, Satheesan A, Ravi S, Thulukanam J (2024) Antibiotics and the gut microbiome: understanding the impact on human health. Med Microecol 20:100106","journal-title":"Med Microecol"},{"issue":"1","key":"1556_CR76","doi-asserted-by":"publisher","first-page":"194","DOI":"10.2337\/db12-0420","volume":"62","author":"H-M Lee","year":"2012","unstructured":"Lee H-M, Kim J-J, Kim HJ, Shong M, Ku BJ, Jo E-K (2012) Upregulated NLRP3 inflammasome activation in patients with type 2 diabetes. Diabetes 62(1):194\u2013204","journal-title":"Diabetes"},{"key":"1556_CR77","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.mce.2016.06.008","volume":"434","author":"A Li","year":"2016","unstructured":"Li A, Zhang S, Li J, Liu K, Huang F, Liu B (2016) Metformin and resveratrol inhibit Drp1-mediated mitochondrial fission and prevent ER stress-associated NLRP3 inflammasome activation in the adipose tissue of diabetic mice. Mol Cell Endocrinol 434:36\u201347","journal-title":"Mol Cell Endocrinol"},{"key":"1556_CR78","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.freeradbiomed.2019.09.015","volume":"145","author":"X-X Li","year":"2019","unstructured":"Li X-X, Ling S-K, Hu M-Y, Ma Y, Li Y, Huang P-L (2019) Protective effects of acarbose against vascular endothelial dysfunction through inhibiting Nox4\/NLRP3 inflammasome pathway in diabetic rats. Free Radic Biol Med 145:175\u2013186","journal-title":"Free Radic Biol Med"},{"issue":"7","key":"1556_CR79","doi-asserted-by":"publisher","first-page":"293","DOI":"10.4239\/wjd.v11.i7.293","volume":"11","author":"W-Z Li","year":"2020","unstructured":"Li W-Z, Stirling K, Yang J-J, Zhang L (2020) Gut microbiota and diabetes: from correlation to causality and mechanism. World J Diabetes 11(7):293\u2013308","journal-title":"World J Diabetes"},{"key":"1556_CR80","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.728047","author":"R Li","year":"2021","unstructured":"Li R et al (2021) Antidiabetic DPP-4 inhibitors reprogram tumor microenvironment that facilitates murine breast cancer metastasis through interaction with cancer cells via a ROS\u2013NF-\u043aB\u2013NLRP3 Axis. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2021.728047","journal-title":"Front Oncol"},{"issue":"1","key":"1556_CR81","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12902-024-01557-w","volume":"24","author":"J Li","year":"2024","unstructured":"Li J, Wang C, Shao C, Xu J (2024a) Expression and diagnostic value of lncRNA MALAT1 and NLRP3 in lower limb atherosclerosis in diabetes. BMC Endocr Disord 24(1):28","journal-title":"BMC Endocr Disord"},{"issue":"2","key":"1556_CR82","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s00592-023-02184-y","volume":"61","author":"X Li","year":"2024","unstructured":"Li X et al (2024b) GLP-1RAs inhibit the activation of the NLRP3 inflammasome signaling pathway to regulate mouse renal podocyte pyroptosis. Acta Diabetol 61(2):225\u2013234","journal-title":"Acta Diabetol"},{"issue":"5","key":"1556_CR83","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/s41374-019-0355-1","volume":"100","author":"Y Liu","year":"2020","unstructured":"Liu Y, Bi X, Zhang Y, Wang Y, Ding W (2020) Mitochondrial dysfunction\/NLRP3 inflammasome axis contributes to angiotensin II-induced skeletal muscle wasting via PPAR-\u03b3. Lab Investig 100(5):712\u2013726","journal-title":"Lab Investig"},{"key":"1556_CR84","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.667644","volume":"12","author":"B-H Liu","year":"2021","unstructured":"Liu B-H et al (2021) Total flavones of abelmoschus manihot ameliorates podocyte pyroptosis and injury in high glucose conditions by targeting METTL3-dependent m(6)A modification-mediated NLRP3-inflammasome activation and PTEN\/PI3K\/Akt Signaling. Front Pharmacol 12:667644","journal-title":"Front Pharmacol"},{"key":"1556_CR85","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.839174","volume":"9","author":"Y Liu","year":"2022","unstructured":"Liu Y et al (2022) Fructose induces insulin resistance of gestational diabetes mellitus in mice via the NLRP3 inflammasome pathway. Front Nutr 9:839174","journal-title":"Front Nutr"},{"issue":"4","key":"1556_CR86","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s00592-022-02021-8","volume":"60","author":"Y Liu","year":"2023","unstructured":"Liu Y et al (2023) LncRNA SNHG16 regulates RAS and NF-\u03baB pathway-mediated NLRP3 inflammasome activation to aggravate diabetes nephropathy through stabilizing TLR4. Acta Diabetol 60(4):563\u2013577","journal-title":"Acta Diabetol"},{"key":"1556_CR87","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.736316","author":"L Lu","year":"2021","unstructured":"Lu L, Zou G, Chen L, Lu Q, Wu M, Li C (2021) Elevated NLRP3 inflammasome levels correlate with vitamin D in the vitreous of proliferative diabetic retinopathy. Front Med. https:\/\/doi.org\/10.3389\/fmed.2021.736316","journal-title":"Front Med"},{"issue":"2","key":"1556_CR88","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1080\/09513590.2021.2015760","volume":"38","author":"L Lu","year":"2022","unstructured":"Lu L, Wang Z, Zhang H, Liu T, Fang H (2022) Drynaria fortunei improves lipid profiles of elderly patients with postmenopausal osteoporosis via regulation of Notch1-NLRP3 inflammasome-mediated inflammation. Gynecol Endocrinol off J Int Soc Gynecol Endocrinol 38(2):176\u2013180","journal-title":"Gynecol Endocrinol off J Int Soc Gynecol Endocrinol"},{"key":"1556_CR89","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1052756","author":"S Lu","year":"2023","unstructured":"Lu S et al (2023) Role of the inflammasome in insulin resistance and type 2 diabetes mellitus. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2023.1052756","journal-title":"Front Immunol"},{"issue":"3","key":"1556_CR90","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1111\/cts.12961","volume":"14","author":"M Lucaf\u00f2","year":"2021","unstructured":"Lucaf\u00f2 M et al (2021) Hypomethylation of NLRP3 gene promoter discriminates glucocorticoid-resistant from glucocorticoid-sensitive idiopathic nephrotic syndrome patients. Clin Transl Sci 14(3):964\u2013975","journal-title":"Clin Transl Sci"},{"key":"1556_CR91","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.abb.2019.07.008","volume":"671","author":"X Luo","year":"2019","unstructured":"Luo X et al (2019) Dulaglutide inhibits high glucose- induced endothelial dysfunction and NLRP3 inflammasome activation. Arch Biochem Biophys 671:203\u2013209","journal-title":"Arch Biochem Biophys"},{"issue":"1","key":"1556_CR92","doi-asserted-by":"publisher","first-page":"2165103","DOI":"10.1080\/0886022X.2023.2165103","volume":"45","author":"C Lv","year":"2023","unstructured":"Lv C, Cheng T, Zhang B, Sun K, Lu K (2023) Triptolide protects against podocyte injury in diabetic nephropathy by activating the Nrf2\/HO-1 pathway and inhibiting the NLRP3 inflammasome pathway. Ren Fail 45(1):2165103","journal-title":"Ren Fail"},{"issue":"8","key":"1556_CR93","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.7150\/ijbs.59965","volume":"17","author":"X Ma","year":"2021","unstructured":"Ma X et al (2021) GLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential. Int J Biol Sci 17(8):2050\u20132068","journal-title":"Int J Biol Sci"},{"issue":"6510","key":"1556_CR94","doi-asserted-by":"publisher","first-page":"8995","DOI":"10.1126\/science.aas8995","volume":"369","author":"VG Magupalli","year":"2020","unstructured":"Magupalli VG et al (2020) HDAC6 mediates an aggresome-like mechanism for NLRP3 and pyrin inflammasome activation. Science 369(6510):8995","journal-title":"Science"},{"key":"1556_CR95","doi-asserted-by":"publisher","DOI":"10.1016\/j.jri.2023.104171","volume":"161","author":"CJ McElwain","year":"2024","unstructured":"McElwain CJ, Musumeci A, Manna S, McCarthy FP, McCarthy CM (2024) L-ergothioneine reduces mitochondrial-driven NLRP3 activation in gestational diabetes mellitus. J Reprod Immunol 161:104171","journal-title":"J Reprod Immunol"},{"key":"1556_CR96","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106820","volume":"87","author":"S Mehta","year":"2020","unstructured":"Mehta S, Vijayvergiya R, Dhawan V (2020) Activation of NLRP3 inflammasome assembly is associated with smoking status of patients with coronary artery disease. Int Immunopharmacol 87:106820","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"1556_CR97","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41419-021-04484-z","volume":"13","author":"L Meng","year":"2022","unstructured":"Meng L, Lin H, Huang X, Weng J, Peng F, Wu S (2022) METTL14 suppresses pyroptosis and diabetic cardiomyopathy by downregulating TINCR lncRNA. Cell Death Dis 13(1):38","journal-title":"Cell Death Dis"},{"key":"1556_CR98","doi-asserted-by":"publisher","first-page":"205873842110383","DOI":"10.1177\/20587384211038357","volume":"35","author":"W Mori","year":"2021","unstructured":"Mori W, Kaneko N, Nakanishi A, Zako T, Masumoto J (2021) Insulin amyloid fibrils interact directly with the NLRP3, resulting in inflammasome activation and pyroptotic cell death. Int J Immunopathol Pharmacol 35:20587384211038356","journal-title":"Int J Immunopathol Pharmacol"},{"key":"1556_CR99","doi-asserted-by":"publisher","DOI":"10.4103\/1735-5362.323920","author":"RE Mostafa","year":"2021","unstructured":"Mostafa RE, Morsi AH, Asaad GF (2021) Anti-inflammatory effects of saxagliptin and vildagliptin against doxorubicin-induced nephrotoxicity in rats: attenuation of NLRP3 inflammasome up-regulation and tubulo-interstitial injury. Res Pharm Sci. https:\/\/doi.org\/10.4103\/1735-5362.323920","journal-title":"Res Pharm Sci"},{"issue":"4","key":"1556_CR100","doi-asserted-by":"publisher","first-page":"2664","DOI":"10.1007\/s13311-021-01140-4","volume":"18","author":"RN Muhammad","year":"2021","unstructured":"Muhammad RN, Ahmed LA, Abdul Salam RM, Ahmed KA, Attia AS (2021) Crosstalk among NLRP3 inflammasome, ETBR signaling, and miRNAs in stress-induced depression-like behavior: a modulatory role for SGLT2 inhibitors. Neurotherapeutics 18(4):2664\u20132681","journal-title":"Neurotherapeutics"},{"issue":"8","key":"1556_CR101","doi-asserted-by":"publisher","first-page":"6250","DOI":"10.1021\/acs.jmedchem.2c00149","volume":"65","author":"P Narros-Fern\u00e1ndez","year":"2022","unstructured":"Narros-Fern\u00e1ndez P et al (2022) Synthesis and pharmacological evaluation of new N-sulfonylureas as NLRP3 inflammasome inhibitors: identification of a hit compound to treat gout. J Med Chem 65(8):6250\u20136260","journal-title":"J Med Chem"},{"issue":"1","key":"1556_CR102","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/ars.2016.6669","volume":"27","author":"Z-W Ning","year":"2016","unstructured":"Ning Z-W et al (2016) MicroRNA-21 mediates angiotensin II-induced liver fibrosis by activating NLRP3 inflammasome\/IL-1\u03b2 axis via targeting smad7 and spry1. Antioxid Redox Signal 27(1):1\u201320","journal-title":"Antioxid Redox Signal"},{"key":"1556_CR103","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.820541","volume":"13","author":"Y Niu","year":"2022","unstructured":"Niu Y et al (2022) Canagliflozin ameliorates NLRP3 inflammasome-mediated inflammation through inhibiting NF-\u03baB signaling and upregulating Bif-1. Front Pharmacol 13:820541","journal-title":"Front Pharmacol"},{"issue":"1","key":"1556_CR104","first-page":"5350999","volume":"2023","author":"B Niu","year":"2023","unstructured":"Niu B, Xia X, Ma L, Yao L, Zhang Y, Su H (2023) LncRNA AC040162.3 promotes HCV-induced T2DM deterioration through the miRNA-223\u20133p\/NLRP3 molecular axis. Anal Cell Pathol 2023(1):5350999","journal-title":"Anal Cell Pathol"},{"issue":"2","key":"1556_CR105","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/jdi.13930","volume":"14","author":"K Oda","year":"2023","unstructured":"Oda K, Miyamoto S, Kodera R, Wada J, Shikata K (2023) Suramin prevents the development of diabetic kidney disease by inhibiting NLRP3 inflammasome activation in KK-Ay mice. J Diabetes Investig 14(2):205\u2013220","journal-title":"J Diabetes Investig"},{"key":"1556_CR106","doi-asserted-by":"publisher","DOI":"10.1016\/j.mvr.2023.104491","volume":"147","author":"H Ouyang","year":"2023","unstructured":"Ouyang H, Wang Y, Wu J, Ji Y (2023) Mechanisms of pulmonary microvascular endothelial cells barrier dysfunction induced by LPS: The roles of ceramides and the Txnip\/NLRP3 inflammasome. Microvasc Res 147:104491","journal-title":"Microvasc Res"},{"issue":"1","key":"1556_CR107","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1161\/CIRCGENETICS.114.000671","volume":"8","author":"F Paneni","year":"2015","unstructured":"Paneni F et al (2015) Adverse epigenetic signatures by histone methyltransferase Set7 contribute to vascular dysfunction in patients with type 2 diabetes mellitus. Circ Cardiovasc Genet 8(1):150\u2013158","journal-title":"Circ Cardiovasc Genet"},{"issue":"2","key":"1556_CR108","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1002\/cpdd.1162","volume":"12","author":"DV Parmar","year":"2023","unstructured":"Parmar DV et al (2023) Safety, tolerability, pharmacokinetics, and pharmacodynamics of the oral NLRP3 inflammasome inhibitor ZYIL1: first-in-human phase 1 studies (single ascending dose and multiple ascending dose). Clin Pharmacol Drug Dev 12(2):202\u2013211","journal-title":"Clin Pharmacol Drug Dev"},{"key":"1556_CR109","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.3389\/fphys.2019.01557","volume":"10","author":"CA Pereira","year":"2020","unstructured":"Pereira CA et al (2020) Mitochondrial DNA promotes NLRP3 inflammasome activation and contributes to endothelial dysfunction and inflammation in type 1 diabetes. Front Physiol 10:1557","journal-title":"Front Physiol"},{"issue":"1","key":"1556_CR110","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1080\/21691401.2019.1578783","volume":"47","author":"Y Qi","year":"2019","unstructured":"Qi Y, Du X, Yao X, Zhao Y (2019) Vildagliptin inhibits high free fatty acid (FFA)-induced NLRP3 inflammasome activation in endothelial cells. Artif Cells Nanomed Biotechnol 47(1):1067\u20131074","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"2","key":"1556_CR111","first-page":"655","volume":"11","author":"L Qing","year":"2019","unstructured":"Qing L, Fu J, Wu P, Zhou Z, Yu F, Tang J (2019) Metformin induces the M2 macrophage polarization to accelerate the wound healing via regulating AMPK\/mTOR\/NLRP3 inflammasome singling pathway. Am J Transl Res 11(2):655\u2013668","journal-title":"Am J Transl Res"},{"issue":"5","key":"1556_CR112","first-page":"223","volume":"12","author":"P Rai","year":"2019","unstructured":"Rai P, Dwibedi N, Rowneki M, Helmer DA, Sambamoorthi U (2019) Dipeptidyl peptidase-4 inhibitors and joint pain: a retrospective cohort study of older veterans with type 2 diabetes mellitus. Am Heal Drug Benefits 12(5):223\u2013231","journal-title":"Am Heal Drug Benefits"},{"key":"1556_CR113","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9111614","author":"AB Raneros","year":"2021","unstructured":"Raneros AB, Bernet CR, Fl\u00f3rez AB, Suarez-Alvarez B (2021) An epigenetic insight into NLRP3 inflammasome activation in inflammation-related processes. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines9111614","journal-title":"Biomedicines"},{"issue":"9","key":"1556_CR114","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1139\/cjpp-2020-0321","volume":"99","author":"G Ren","year":"2021","unstructured":"Ren G, Zhou Q, Lu M, Wang H (2021) Rosuvastatin corrects oxidative stress and inflammation induced by LPS to attenuate cardiac injury by inhibiting the NLRP3\/TLR4 pathway. Can J Physiol Pharmacol 99(9):964\u2013973","journal-title":"Can J Physiol Pharmacol"},{"issue":"10","key":"1556_CR115","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.2337\/db18-0537","volume":"67","author":"ED Rosen","year":"2018","unstructured":"Rosen ED et al (2018) Epigenetics and epigenomics: implications for diabetes and obesity. Diabetes 67(10):1923\u20131931","journal-title":"Diabetes"},{"key":"1556_CR116","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2020.155101","volume":"131","author":"N Roshanravan","year":"2020","unstructured":"Roshanravan N et al (2020) Effects of oral butyrate and inulin supplementation on inflammation-induced pyroptosis pathway in type 2 diabetes: a randomized, double-blind, placebo-controlled trial. Cytokine 131:155101","journal-title":"Cytokine"},{"key":"1556_CR117","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2023.1130625","author":"K Saini","year":"2023","unstructured":"Saini K, Sharma S, Khan Y (2023) DPP-4 inhibitors for treating T2DM - hype or hope? An analysis based on the current literature. Front Mol Biosci. https:\/\/doi.org\/10.3389\/fmolb.2023.1130625","journal-title":"Front Mol Biosci"},{"issue":"2","key":"1556_CR118","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/diseases8020014","volume":"8","author":"Y Saisho","year":"2020","unstructured":"Saisho Y (2020) SGLT2 inhibitors: the star in the treatment of type 2 diabetes? Diseases 8(2):14","journal-title":"Diseases"},{"key":"1556_CR119","doi-asserted-by":"publisher","DOI":"10.1016\/j.deman.2021.100002","volume":"1","author":"AJ Scheen","year":"2021","unstructured":"Scheen AJ (2021) Sulphonylureas in the management of type 2 diabetes: to be or not to be? Diabetes Epidemiol Manag 1:100002","journal-title":"Diabetes Epidemiol Manag"},{"issue":"8","key":"1556_CR120","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0290532","volume":"18","author":"H-Y Seo","year":"2023","unstructured":"Seo H-Y et al (2023) Lobeglitazone inhibits LPS-induced NLRP3 inflammasome activation and inflammation in the liver. PLoS ONE 18(8):e0290532","journal-title":"PLoS ONE"},{"issue":"1","key":"1556_CR121","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/ki.2014.271","volume":"87","author":"K Shahzad","year":"2015","unstructured":"Shahzad K et al (2015) Nlrp3-inflammasome activation in non-myeloid-derived cells aggravates diabetic nephropathy. Kidney Int 87(1):74\u201384","journal-title":"Kidney Int"},{"issue":"3","key":"1556_CR122","doi-asserted-by":"publisher","first-page":"772","DOI":"10.2337\/db20-0357","volume":"70","author":"A Sharma","year":"2020","unstructured":"Sharma A et al (2020) Specific NLRP3 inhibition protects against diabetes-associated atherosclerosis. Diabetes 70(3):772\u2013787","journal-title":"Diabetes"},{"issue":"1","key":"1556_CR123","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13098-021-00780-y","volume":"14","author":"J Shen","year":"2022","unstructured":"Shen J, Dai Z, Li Y, Zhu H, Zhao L (2022) TLR9 regulates NLRP3 inflammasome activation via the NF-kB signaling pathway in diabetic nephropathy. Diabetol Metab Syndr 14(1):26","journal-title":"Diabetol Metab Syndr"},{"issue":"17","key":"1556_CR124","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.3748\/wjg.v28.i17.1814","volume":"28","author":"FM Silva-Veiga","year":"2022","unstructured":"Silva-Veiga FM et al (2022) Peroxisome proliferator-activated receptor-alpha activation and dipeptidyl peptidase-4 inhibition target dysbiosis to treat fatty liver in obese mice. World J Gastroenterol 28(17):1814\u20131829","journal-title":"World J Gastroenterol"},{"key":"1556_CR125","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1016\/j.atherosclerosis.2023.06.727","volume":"379","author":"D Singla","year":"2023","unstructured":"Singla D, Narasimhulu C (2023) BMP-7 attenuates TLR4-NLRP3 inflammasome mediated pyroptosis in vascular smooth muscle cells in atherosclerotic plaques. Atherosclerosis 379:S15\u2013S16","journal-title":"Atherosclerosis"},{"issue":"2","key":"1556_CR126","first-page":"e00730","volume":"9","author":"Q Siwen","year":"2021","unstructured":"Siwen Q et al (2021) Akkermansia muciniphila alleviates dextran sulfate sodium (DSS)-induced acute colitis by NLRP3 activation. Microbiol Spectr 9(2):e00730-e821","journal-title":"Microbiol Spectr"},{"issue":"1","key":"1556_CR127","doi-asserted-by":"publisher","first-page":"21006","DOI":"10.1038\/s41598-020-76497-1","volume":"10","author":"M Sokolova","year":"2020","unstructured":"Sokolova M et al (2020) NLRP3 inflammasome deficiency attenuates metabolic disturbances involving alterations in the gut microbial profile in mice exposed to high fat diet. Sci Rep 10(1):21006","journal-title":"Sci Rep"},{"issue":"3","key":"1556_CR128","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1530\/JME-18-0069","volume":"61","author":"S Song","year":"2018","unstructured":"Song S et al (2018) Knockdown of NLRP3 alleviates high glucose or TGFB1-induced EMT in human renal tubular cells. J Mol Endocrinol 61(3):101\u2013113","journal-title":"J Mol Endocrinol"},{"key":"1556_CR129","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2023.101806","volume":"78","author":"Y Song","year":"2023","unstructured":"Song Y et al (2023) Gemigliptin, a DPP4 inhibitor, ameliorates nonalcoholic steatohepatitis through AMP-activated protein kinase-independent and ULK1-mediated autophagy. Mol Metab 78:101806","journal-title":"Mol Metab"},{"key":"1556_CR130","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2020.109825","volume":"77","author":"S Sukhanov","year":"2021","unstructured":"Sukhanov S et al (2021) The SGLT2 inhibitor Empagliflozin attenuates interleukin-17A-induced human aortic smooth muscle cell proliferation and migration by targeting TRAF3IP2\/ROS\/NLRP3\/Caspase-1-dependent IL-1\u03b2 and IL-18 secretion. Cell Signal 77:109825","journal-title":"Cell Signal"},{"issue":"10","key":"1556_CR131","doi-asserted-by":"publisher","first-page":"e3074","DOI":"10.1038\/cddis.2017.470","volume":"8","author":"H-J Sun","year":"2017","unstructured":"Sun H-J et al (2017) NLRP3 inflammasome activation contributes to VSMC phenotypic transformation and proliferation in hypertension. Cell Death Dis 8(10):e3074\u2013e3074","journal-title":"Cell Death Dis"},{"key":"1556_CR132","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.14826","volume":"11","author":"L Sun","year":"2023","unstructured":"Sun L, Ding M, Chen F, Zhu D, Xie X (2023) Breviscapine alleviates podocyte injury by inhibiting NF-\u03baB\/NLRP3-mediated pyroptosis in diabetic nephropathy. PeerJ 11:e14826","journal-title":"PeerJ"},{"issue":"1","key":"1556_CR133","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1186\/s12967-022-03585-3","volume":"20","author":"J Tan","year":"2022","unstructured":"Tan J et al (2022) Probiotics ameliorate IgA nephropathy by improving gut dysbiosis and blunting NLRP3 signaling. J Transl Med 20(1):382","journal-title":"J Transl Med"},{"key":"1556_CR134","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109410","volume":"119","author":"G Tang","year":"2019","unstructured":"Tang G et al (2019) Metformin inhibited Nod-like receptor protein 3 inflammasomes activation and suppressed diabetes-accelerated atherosclerosis in apoE\u2212\/\u2212 mice. Biomed Pharmacother 119:109410","journal-title":"Biomed Pharmacother"},{"issue":"7","key":"1556_CR135","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1007\/s13300-021-01058-2","volume":"12","author":"JL Tarry-Adkins","year":"2021","unstructured":"Tarry-Adkins JL, Grant ID, Ozanne SE, Reynolds RM, Aiken CE (2021) Efficacy and side effect profile of different formulations of metformin: a systematic review and meta-analysis. Diabetes Ther 12(7):1901\u20131914","journal-title":"Diabetes Ther"},{"issue":"4","key":"1556_CR136","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s11892-014-0473-5","volume":"14","author":"PM Thul\u00e9","year":"2014","unstructured":"Thul\u00e9 PM, Umpierrez G (2014) Sulfonylureas: a new look at old therapy. Curr Diab Rep 14(4):473","journal-title":"Curr Diab Rep"},{"key":"1556_CR137","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2023.109603","volume":"237","author":"X Tu","year":"2023","unstructured":"Tu X, Chen P, Chen J, Ding Y, Chen Q, Shi S (2023) GLP-1R knockdown abrogates the protective effects of liraglutide on ischaemic stroke via inhibition of M2 polarisation and activation of NLRP3 inflammasome by reducing Nrf2 activation. Neuropharmacology 237:109603","journal-title":"Neuropharmacology"},{"issue":"7","key":"1556_CR138","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1161\/HYPERTENSIONAHA.121.18477","volume":"79","author":"I Valencia","year":"2022","unstructured":"Valencia I et al (2022) DPP4 promotes human endothelial cell senescence and dysfunction via the PAR2\u2013COX-2\u2013TP axis and NLRP3 inflammasome activation. Hypertension 79(7):1361\u20131373","journal-title":"Hypertension"},{"issue":"1","key":"1556_CR139","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3390\/gastroent15010014","volume":"15","author":"J Wan","year":"2024","unstructured":"Wan J, Ferrari C, Tadros M (2024) GLP-1RA essentials in gastroenterology: side effect management, precautions for endoscopy and applications for gastrointestinal disease treatment. Gastroenterol Insights 15(1):191\u2013212","journal-title":"Gastroenterol Insights"},{"issue":"9","key":"1556_CR140","first-page":"8336","volume":"16","author":"W Wang","year":"2023","unstructured":"Wang W, Zhang J (2023) Teneligliptin alleviates diabetes-related cognitive impairment by inhibiting the endoplasmic reticulum (ER) stress and NLRP3 inflammasome in mice. Aging 16(9):8336\u20138347","journal-title":"Aging"},{"issue":"7","key":"1556_CR141","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1002\/iub.2267","volume":"72","author":"S Wang","year":"2020","unstructured":"Wang S, Du S, Lv Y, Wang W, Zhang F (2020) Elevated microRNA-20b-3p and reduced thioredoxin-interacting protein ameliorate diabetic retinopathy progression by suppressing the NLRP3 inflammasomes. IUBMB Life 72(7):1433\u20131448","journal-title":"IUBMB Life"},{"issue":"1","key":"1556_CR142","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13578-020-00388-1","volume":"10","author":"D Wang","year":"2020","unstructured":"Wang D et al (2020a) P2X7 receptor mediates NLRP3 inflammasome activation in depression and diabetes. Cell Biosci 10(1):28","journal-title":"Cell Biosci"},{"issue":"5","key":"1556_CR143","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s41419-020-2598-6","volume":"11","author":"J Wang","year":"2020","unstructured":"Wang J et al (2020b) High glucose mediates NLRP3 inflammasome activation via upregulation of ELF3 expression. Cell Death Dis 11(5):383","journal-title":"Cell Death Dis"},{"key":"1556_CR144","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241411451","author":"H Wang","year":"2023","unstructured":"Wang H et al (2023) Yersiniabactin-producing E. coli induces the pyroptosis of intestinal epithelial cells via the NLRP3 pathway and promotes gut inflammation. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms241411451","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1556_CR145","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1080\/13880209.2023.2174145","volume":"61","author":"F Wang","year":"2023","unstructured":"Wang F et al (2023) Sanziguben polysaccharides improve diabetic nephropathy in mice by regulating gut microbiota to inhibit the TLR4\/NF-\u03baB\/NLRP3 signalling pathway. Pharm Biol 61(1):427\u2013436","journal-title":"Pharm Biol"},{"key":"1556_CR146","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.phrs.2019.01.035","volume":"142","author":"R Ward","year":"2019","unstructured":"Ward R et al (2019) NLRP3 inflammasome inhibition with MCC950 improves diabetes-mediated cognitive impairment and vasoneuronal remodeling after ischemia. Pharmacol Res 142:237\u2013250","journal-title":"Pharmacol Res"},{"key":"1556_CR147","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.907504","volume":"13","author":"BM Williams","year":"2022","unstructured":"Williams BM, Cliff CL, Lee K, Squires PE, Hills CE (2022) The Role of the NLRP3 inflammasome in mediating glomerular and tubular injury in diabetic nephropathy. Front Physiol 13:907504","journal-title":"Front Physiol"},{"issue":"1","key":"1556_CR148","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/FJC.0000000000000931","volume":"77","author":"GF Wohlford","year":"2020","unstructured":"Wohlford GF et al (2020) Phase 1B, randomized, double-blinded, dose escalation, single-center, repeat dose safety and pharmacodynamics study of the oral NLRP3 Inhibitor dapansutrile in subjects With NYHA II-III systolic heart failure. J Cardiovasc Pharmacol 77(1):49\u201360","journal-title":"J Cardiovasc Pharmacol"},{"issue":"1","key":"1556_CR149","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3892\/etm.2021.11017","volume":"23","author":"W Wu","year":"2022","unstructured":"Wu W et al (2022) NLRP3 inflammasome activation in gestational diabetes mellitus placentas is associated with hydrogen sulfide synthetase deficiency. Exp Ther Med 23(1):94","journal-title":"Exp Ther Med"},{"issue":"5","key":"1556_CR150","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/s00284-023-03252-w","volume":"80","author":"J Wu","year":"2023","unstructured":"Wu J, Zhang D, Zhao M, Zheng X (2023) Gut microbiota dysbiosis and increased NLRP3 levels in patients with pregnancy-induced hypertension. Curr Microbiol 80(5):168","journal-title":"Curr Microbiol"},{"key":"1556_CR151","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2023.112012","volume":"577","author":"X Xi","year":"2023","unstructured":"Xi X, Wang M, Chen Q, Ma J, Zhang J, Li Y (2023) DNMT1 regulates miR-20a\/TXNIP-mediated pyroptosis of retinal pigment epithelial cells through DNA methylation. Mol Cell Endocrinol 577:112012","journal-title":"Mol Cell Endocrinol"},{"key":"1556_CR152","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3389\/fphar.2020.00372","volume":"11","author":"J Xia","year":"2020","unstructured":"Xia J et al (2020) A GLP-1 analog liraglutide reduces intimal hyperplasia after coronary stent implantation via regulation of glycemic variability and NLRP3 Inflammasome\/IL-10 signaling in diabetic swine. Front Pharmacol 11:372","journal-title":"Front Pharmacol"},{"issue":"7","key":"1556_CR153","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1016\/j.immuni.2021.05.004","volume":"54","author":"H Xian","year":"2021","unstructured":"Xian H et al (2021) Metformin inhibition of mitochondrial ATP and DNA synthesis abrogates NLRP3 inflammasome activation and pulmonary inflammation. Immunity 54(7):1463-1477.e11","journal-title":"Immunity"},{"issue":"5","key":"1556_CR154","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1002\/kjm2.12676","volume":"39","author":"J Xiong","year":"2023","unstructured":"Xiong J, Zhou Q (2023) The lncRNA HOTAIR attenuates pyroptosis of diabetic cardiomyocytes by recruiting FUS to regulate SIRT3 expression. Kaohsiung J Med Sci 39(5):458\u2013467","journal-title":"Kaohsiung J Med Sci"},{"issue":"6","key":"1556_CR155","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1007\/s10620-021-07027-w","volume":"67","author":"T Xu","year":"2022","unstructured":"Xu T, Sheng L, Guo X, Ding Z (2022) Free fatty acid increases the expression of NLRP3-caspase1 in adipose tissue macrophages in obese severe acute pancreatitis. Dig Dis Sci 67(6):2220\u20132231","journal-title":"Dig Dis Sci"},{"key":"1556_CR156","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.905363","author":"C Xue","year":"2022","unstructured":"Xue C et al (2022) The relationships between cholesterol crystals, NLRP3 inflammasome, and coronary atherosclerotic plaque vulnerability in acute coronary syndrome: an optical coherence tomography study. Front Cardiovasc Med. https:\/\/doi.org\/10.3389\/fcvm.2022.905363","journal-title":"Front Cardiovasc Med"},{"issue":"28","key":"1556_CR157","doi-asserted-by":"publisher","first-page":"3261","DOI":"10.2174\/0929867329666220922104654","volume":"30","author":"M Yang","year":"2023","unstructured":"Yang M, Zhao L (2023) The selective NLRP3-inflammasome inhibitor CY-09 ameliorates kidney injury in diabetic nephropathy by inhibiting NLRP3- inflammasome activation. Curr Med Chem 30(28):3261\u20133270","journal-title":"Curr Med Chem"},{"key":"1556_CR158","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.trsl.2022.10.008","volume":"254","author":"S Yang","year":"2023","unstructured":"Yang S et al (2023) Disulfiram accelerates diabetic foot ulcer healing by blocking NET formation via suppressing the NLRP3\/Caspase-1\/GSDMD pathway. Transl Res 254:115\u2013127","journal-title":"Transl Res"},{"key":"1556_CR159","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.ejmech.2016.12.020","volume":"126","author":"S Yasmin","year":"2017","unstructured":"Yasmin S, Jayaprakash V (2017) Thiazolidinediones and PPAR orchestra as antidiabetic agents: from past to present. Eur J Med Chem 126:879\u2013893","journal-title":"Eur J Med Chem"},{"key":"1556_CR160","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.907984","author":"T Ye","year":"2022","unstructured":"Ye T et al (2022) Empagliflozin attenuates obesity-related kidney dysfunction and NLRP3 inflammasome activity through the HO-1\u2013adiponectin axis. Front Endocrinol. https:\/\/doi.org\/10.3389\/fendo.2022.907984","journal-title":"Front Endocrinol"},{"issue":"37","key":"1556_CR161","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000035155","volume":"102","author":"H You","year":"2023","unstructured":"You H, Li H, Gou W (2023) lncRNA HOTAIR promotes ROS generation and NLRP3 inflammasome activation by inhibiting Nrf2 in diabetic retinopathy. Medicine (baltimore) 102(37):e35155","journal-title":"Medicine (baltimore)"},{"key":"1556_CR162","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2019.172715","volume":"864","author":"X Yu","year":"2019","unstructured":"Yu X et al (2019) Liraglutide ameliorates non-alcoholic steatohepatitis by inhibiting NLRP3 inflammasome and pyroptosis activation via mitophagy. Eur J Pharmacol 864:172715","journal-title":"Eur J Pharmacol"},{"key":"1556_CR163","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.768214","volume":"8","author":"Y-W Yu","year":"2022","unstructured":"Yu Y-W et al (2022) Sodium-glucose co-transporter-2 inhibitor of dapagliflozin attenuates myocardial ischemia\/reperfusion injury by limiting NLRP3 inflammasome activation and modulating autophagy. Front Cardiovasc Med 8:768214","journal-title":"Front Cardiovasc Med"},{"issue":"4","key":"1556_CR164","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1159\/000508372","volume":"45","author":"J-F Zhan","year":"2020","unstructured":"Zhan J-F, Huang H-W, Huang C, Hu L-L, Xu W-W (2020) Long non-coding RNA NEAT1 regulates pyroptosis in diabetic nephropathy via mediating the miR-34c\/NLRP3 Axis. Kidney Blood Press Res 45(4):589\u2013602","journal-title":"Kidney Blood Press Res"},{"issue":"1","key":"1556_CR165","doi-asserted-by":"publisher","first-page":"5015","DOI":"10.1038\/s41467-020-18414-8","volume":"11","author":"Y Zhang","year":"2020","unstructured":"Zhang Y et al (2020) Gut microbiome-related effects of berberine and probiotics on type 2 diabetes (the PREMOTE study). Nat Commun 11(1):5015","journal-title":"Nat Commun"},{"issue":"23","key":"1556_CR166","doi-asserted-by":"publisher","first-page":"24270","DOI":"10.18632\/aging.202143","volume":"12","author":"J Zhang","year":"2020","unstructured":"Zhang J et al (2020) Metformin protects against myocardial ischemia-reperfusion injury and cell pyroptosis via AMPK\/NLRP3 inflammasome pathway. Aging 12(23):24270\u201324287","journal-title":"Aging"},{"issue":"1","key":"1556_CR167","doi-asserted-by":"publisher","first-page":"1806344","DOI":"10.1155\/2021\/1806344","volume":"2021","author":"Y Zhang","year":"2021","unstructured":"Zhang Y et al (2021) Metformin corrects glucose metabolism reprogramming and NLRP3 inflammasome-induced pyroptosis via inhibiting the TLR4\/NF-\u03baB\/PFKFB3 signaling in trophoblasts: implication for a potential therapy of preeclampsia. Oxid Med Cell Longev 2021(1):1806344","journal-title":"Oxid Med Cell Longev"},{"issue":"7","key":"1556_CR168","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/s41419-021-03930-2","volume":"12","author":"X Zhang","year":"2021","unstructured":"Zhang X et al (2021) TXNIP, a novel key factor to cause Schwann cell dysfunction in diabetic peripheral neuropathy, under the regulation of PI3K\/Akt pathway inhibition-induced DNMT1 and DNMT3a overexpression. Cell Death Dis 12(7):642","journal-title":"Cell Death Dis"},{"issue":"3","key":"1556_CR169","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1093\/cvr\/cvab114","volume":"118","author":"Y Zhang","year":"2022","unstructured":"Zhang Y et al (2022) Gut microbiota dysbiosis promotes age-related atrial fibrillation by lipopolysaccharide and glucose-induced activation of NLRP3-inflammasome. Cardiovasc Res 118(3):785\u2013797","journal-title":"Cardiovasc Res"},{"key":"1556_CR170","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2022.116645","volume":"58","author":"C Zhang","year":"2022","unstructured":"Zhang C et al (2022a) Targeting NLRP3 signaling by a novel-designed sulfonylurea compound for inhibition of microglial inflammation. Bioorg Med Chem 58:116645","journal-title":"Bioorg Med Chem"},{"key":"1556_CR171","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2022.109806","volume":"186","author":"Q Zhang","year":"2022","unstructured":"Zhang Q et al (2022b) Glucagon-like peptide-1 receptor agonist attenuates diabetic neuropathic pain via inhibition of NOD-like receptor protein 3 inflammasome in brain microglia. Diabetes Res Clin Pract 186:109806","journal-title":"Diabetes Res Clin Pract"},{"key":"1556_CR172","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2023.106237","volume":"182","author":"Y Zhang","year":"2023","unstructured":"Zhang Y et al (2023) Lactobacillus plantarum NC8 and its metabolite acetate alleviate type 1 diabetes via inhibiting NLRP3. Microb Pathog 182:106237","journal-title":"Microb Pathog"},{"issue":"1","key":"1556_CR173","first-page":"9956950","volume":"2023","author":"Z Zhang","year":"2023","unstructured":"Zhang Z et al (2023) Schisandrin B alleviates diabetic cardiac autonomic neuropathy induced by p2x7 receptor in superior cervical ganglion via NLRP3. Dis Markers 2023(1):9956950","journal-title":"Dis Markers"},{"key":"1556_CR174","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116807","volume":"176","author":"J Zhao","year":"2024","unstructured":"Zhao J et al (2024) New insights into the interplay between autophagy, gut microbiota and insulin resistance in metabolic syndrome. Biomed Pharmacother 176:116807","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"1556_CR175","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41421-020-0167-x","volume":"6","author":"D Zheng","year":"2020","unstructured":"Zheng D, Liwinski T, Elinav E (2020) Inflammasome activation and regulation: toward a better understanding of complex mechanisms. Cell Discov 6(1):36","journal-title":"Cell Discov"},{"key":"1556_CR176","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1151185","author":"X Zheng","year":"2023","unstructured":"Zheng X, Wan J, Tan G (2023) The mechanisms of NLRP3 inflammasome\/pyroptosis activation and their role in diabetic retinopathy. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2023.1151185","journal-title":"Front Immunol"},{"issue":"1","key":"1556_CR177","first-page":"5584894","volume":"2023","author":"S Zheng","year":"2023","unstructured":"Zheng S et al (2023) Human umbilical cord mesenchymal stem cells inhibit pyroptosis of renal tubular epithelial cells through miR-342-3p\/caspase1 signaling pathway in diabetic nephropathy. Stem Cells Int 2023(1):5584894","journal-title":"Stem Cells Int"},{"key":"1556_CR178","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00709","author":"Z Zhou","year":"2018","unstructured":"Zhou Z et al (2018) Association analysis of NLRP3 inflammation-related gene promotor methylation as well as mediating effects on T2DM and vascular complications in a southern han chinese population. Front Endocrinol (lausanne). https:\/\/doi.org\/10.3389\/fendo.2018.00709","journal-title":"Front Endocrinol (lausanne)"},{"issue":"10","key":"1556_CR179","doi-asserted-by":"publisher","first-page":"4429","DOI":"10.18632\/aging.204745","volume":"15","author":"L-H Zhou","year":"2023","unstructured":"Zhou L-H et al (2023) Metformin inhibits ovarian granular cell pyroptosis through the miR-670\u20133p\/NOX2\/ROS pathway. Aging 15(10):4429\u20134443","journal-title":"Aging"},{"key":"1556_CR180","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109543","volume":"114","author":"J Zhou","year":"2023","unstructured":"Zhou J et al (2023) Salidroside protects pancreatic \u03b2-cells against pyroptosis by regulating the NLRP3\/GSDMD pathway in diabetic conditions. Int Immunopharmacol 114:109543","journal-title":"Int Immunopharmacol"},{"issue":"26","key":"1556_CR181","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202308786","volume":"11","author":"X Zhou","year":"2024","unstructured":"Zhou X et al (2024) Inhibition of METTL3 alleviates NLRP3 inflammasome activation via increasing ubiquitination of NEK7. Adv Sci 11(26):e2308786","journal-title":"Adv Sci"},{"issue":"4","key":"1556_CR182","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2021.101843","volume":"46","author":"X Zhu","year":"2022","unstructured":"Zhu X, Lin X, Zhang P, Liu Y, Ling W, Guo H (2022) Upregulated NLRP3 inflammasome activation is attenuated by anthocyanins in patients with nonalcoholic fatty liver disease: a case-control and an intervention study. Clin Res Hepatol Gastroenterol 46(4):101843","journal-title":"Clin Res Hepatol Gastroenterol"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-024-01556-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-024-01556-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-024-01556-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,21]],"date-time":"2024-09-21T13:05:09Z","timestamp":1726923909000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-024-01556-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,19]]},"references-count":182,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["1556"],"URL":"https:\/\/doi.org\/10.1007\/s10787-024-01556-2","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,19]]},"assertion":[{"value":"4 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}